Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.92% |
| 2 | Healthcare | 11.63% |
| 3 | Technology | 11.35% |
| 4 | Industrials | 10.55% |
| 5 | Consumer Staples | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
McDonald's
MCD
$194B
| $76.6M | 0.15% |
+609,500
| New | +$72.8M |
|
127
WD-40
WDFC
$3.13B
| $76.5M | 0.15% |
708,000
+47,400
| +7% | +$4.9M |
|
128
Tyson Foods
TSN
$19.9B
| $76.1M | 0.14% |
1,141,800
-594,100
| -34% | -$35.7M |
|
129
Best Buy
BBY
$17.6B
| $76.1M | 0.14% |
+2,345,400
| New | +$71.1M |
|
|
K
130
DELISTED
Kellanova
K
| $75.9M | 0.14% |
+1,055,948
| New | +$72.9M |
|
|
MBT
131
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $75.1M | 0.14% |
9,286,450
+1,552,900
| +20% | +$10.8M |
|
132
Toyota
TM
$225B
| $75M | 0.14% |
705,700
+150,400
| +27% | +$16.6M |
|
133
Equity Lifestyle Properties
ELS
$12.4B
| $74.6M | 0.14% |
2,052,600
+323,200
| +19% | +$11.1M |
|
134
Lockheed Martin
LMT
$138B
| $74.6M | 0.14% |
336,800
+323,800
| +2,491% | +$69.7M |
|
135
ResMed
RMD
$32.6B
| $74.2M | 0.14% |
1,283,100
+17,000
| +1% | +$962K |
|
|
NLSN
136
DELISTED
Nielsen Holdings plc
NLSN
| $73.6M | 0.14% |
1,398,500
+1,267,300
| +966% | +$61.3M |
|
137
UDR
UDR
$12B
| $72.9M | 0.14% |
1,890,898
+709,598
| +60% | +$25.4M |
|
138
Ambev
ABEV
$43.8B
| $72.5M | 0.14% |
14,004,239
+3,996,400
| +40% | +$18.4M |
|
139
Royal Bank of Canada
RY
$292B
| $72.5M | 0.14% |
1,258,983
-31,094
| -2% | -$1.61M |
|
|
ISBC
140
DELISTED
Investors Bancorp, Inc.
ISBC
| $72.2M | 0.14% |
6,205,325
+1,053,338
| +20% | +$12.1M |
|
141
Charles River Laboratories
CRL
$13.5B
| $72.2M | 0.14% |
950,209
+77,700
| +9% | +$5.75M |
|
142
Amgen
AMGN
$224B
| $72.1M | 0.14% |
481,200
+334,700
| +228% | +$49.7M |
|
143
Fidelity National Financial
FNF
$12.8B
| $72M | 0.14% |
3,058,999
+1,477,994
| +93% | +$33.1M |
|
|
SOHU
144
Sohu.com
SOHU
$371M
| $71.9M | 0.14% |
1,451,600
+224,000
| +18% | +$10.8M |
|
|
145
Pfizer
PFE
$152B
| $71.6M | 0.14% |
2,546,823
-5,869,726
| -70% | -$168M |
|
146
Synchrony
SYF
$25.5B
| $71.2M | 0.14% |
2,482,900
+656,300
| +36% | +$18.2M |
|
147
Arch Capital
ACGL
$33.5B
| $71M | 0.14% |
2,995,800
+354,000
| +13% | +$8.06M |
|
148
Exelon
EXC
$46.2B
| $70.5M | 0.13% |
2,756,893
+1,099,555
| +66% | +$24.6M |
|
|
TARO
149
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $70.4M | 0.13% |
491,300
+40,100
| +9% | +$5.7M |
|
150
Ameren
AEE
$29.8B
| $69.4M | 0.13% |
1,385,600
+334,400
| +32% | +$15.4M |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.